{"id":"https://openalex.org/W3034818582","doi":null,"title":"An In Vitro Evaluation of the Anti-Cancer Potential of Novel 1, 2, 4, 5-Tetraoxanes for Chronic Lymphocytic Leukemia at Physiologically Relevant Oxygen Tension","display_name":"An In Vitro Evaluation of the Anti-Cancer Potential of Novel 1, 2, 4, 5-Tetraoxanes for Chronic Lymphocytic Leukemia at Physiologically Relevant Oxygen Tension","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3034818582","mag":"3034818582"},"language":"en","primary_location":{"id":"mag:3034818582","doi":null,"is_oa":false,"landing_page_url":"https://www.imedpub.com/articles/an-in-vitro-evaluation-of-the-anticancer-potential-of-novel-1-2-4-5tetraoxanes-for-chronic-lymphocytic-leukemia-at--physiologicall.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764959377","display_name":"European Journal of Experimental Biology","issn_l":"2248-9215","issn":["2248-9215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4327876851","host_organization_name":"Insight Medical Publishing","host_organization_lineage":["https://openalex.org/P4327876851"],"host_organization_lineage_names":["Insight Medical Publishing"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Experimental Biology","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026695621","display_name":"Alma O Reilly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alma O Reilly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038788848","display_name":"Sarah Louise Rawe","orcid":"https://orcid.org/0000-0003-0940-8371","observed_orcids":["https://orcid.org/0000-0003-0940-8371"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah L. Rawe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0940-8371","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Robert W. Redmond","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert W. Redmond","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036960617","display_name":"Elaine Meade","orcid":"https://orcid.org/0000-0002-3867-9712","observed_orcids":["https://orcid.org/0000-0002-3867-9712"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elaine Meade","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3867-9712","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"James E. Murphy","orcid":"https://orcid.org/0000-0002-4113-2160","observed_orcids":["https://orcid.org/0000-0002-4113-2160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James E. Murphy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4113-2160","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012598466","display_name":"Mary Garvey","orcid":"https://orcid.org/0000-0003-1240-5315","observed_orcids":["https://orcid.org/0000-0003-1240-5315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Garvey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1240-5315","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11547","display_name":"Sesquiterpenes and Asteraceae Studies","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/1-2-4-5-tetraoxanes","display_name":"1,2,4,5-tetraoxanes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/dihydroartemisinin","display_name":"dihydroartemisinin","score":0.8899999856948853},{"id":"https://openalex.org/keywords/chlorambucil","display_name":"chlorambucil","score":0.9900000095367432},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9150000214576721},{"id":"https://openalex.org/keywords/oxygen-partial-pressure","display_name":"oxygen partial pressure","score":0.6150000095367432},{"id":"https://openalex.org/keywords/hl-60-cells","display_name":"HL-60 cells","score":0.8309999704360962},{"id":"https://openalex.org/keywords/mec-1-cells","display_name":"MEC-1 cells","score":0.9869999885559082},{"id":"https://openalex.org/keywords/selectivity-index","display_name":"selectivity index","score":0.7639999985694885},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.828000009059906},{"id":"https://openalex.org/keywords/leukemia-cell-lines","display_name":"leukemia cell lines","score":0.5130000114440918}],"concepts":[{"id":"https://openalex.org/C2777866208","wikidata":"https://www.wikidata.org/wiki/Q415939","display_name":"Chlorambucil","level":4,"score":0.9070885181427002},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7237354516983032},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5020186901092529},{"id":"https://openalex.org/C113067387","wikidata":"https://www.wikidata.org/wiki/Q14912836","display_name":"CD5","level":3,"score":0.4966281056404114},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49292588233947754},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.4815424084663391},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48051533102989197},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.42287349700927734},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40688544511795044},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3897826671600342},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3872738480567932},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36611777544021606},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34552592039108276},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.31796973943710327},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1807279884815216},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3034818582","doi":null,"is_oa":false,"landing_page_url":"https://www.imedpub.com/articles/an-in-vitro-evaluation-of-the-anticancer-potential-of-novel-1-2-4-5tetraoxanes-for-chronic-lymphocytic-leukemia-at--physiologicall.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764959377","display_name":"European Journal of Experimental Biology","issn_l":"2248-9215","issn":["2248-9215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4327876851","host_organization_name":"Insight Medical Publishing","host_organization_lineage":["https://openalex.org/P4327876851"],"host_organization_lineage_names":["Insight Medical Publishing"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Experimental Biology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W101553012","https://openalex.org/W1969451624","https://openalex.org/W1994741369","https://openalex.org/W2015619266","https://openalex.org/W2018722597","https://openalex.org/W2033057842","https://openalex.org/W2044811771","https://openalex.org/W2068050279","https://openalex.org/W2080892289","https://openalex.org/W2114958673","https://openalex.org/W2129046210","https://openalex.org/W2129516532","https://openalex.org/W2165573529","https://openalex.org/W2233908128","https://openalex.org/W2550864189","https://openalex.org/W2740623655","https://openalex.org/W2792032937"],"related_works":["https://openalex.org/W2924427969","https://openalex.org/W2920818695","https://openalex.org/W4401323349","https://openalex.org/W107705151","https://openalex.org/W1645100825","https://openalex.org/W2333500221","https://openalex.org/W2305848735","https://openalex.org/W2554781359","https://openalex.org/W2072539551","https://openalex.org/W2038210547"],"abstract_inverted_index":{"Chronic":[0],"Lymphocytic":[1],"Leukemia":[2],"(CLL)":[3],"is":[4,40,71,121],"the":[5,58,93,165,227,240],"most":[6],"prevalent":[7],"leukemia":[8],"amongst":[9],"adults":[10],"in":[11,181],"Europe":[12],"and":[13,36,54,62,100,125,147,171,196,215,262,264],"North":[14],"America":[15],"with":[16,45,74,88,206],"a":[17,84,97,149,249,253,274],"median":[18],"age":[19],"of":[20,22,48,65,69,95,102,145,246,277],"diagnosis":[21],"72":[23],"years.":[24],"Risk":[25],"factors":[26],"for":[27,80,143,177,221],"this":[28],"disease":[29],"include":[30],"sex,":[31],"ethnicity,":[32],"age,":[33],"hereditary":[34],"influences":[35],"xenobiotic":[37],"exposure.":[38],"CLL":[39,70,146],"characterized":[41],"by":[42],"clonal":[43],"proliferation":[44],"progressive":[46],"accretion":[47],"B-cell":[49],"lymphocytes":[50],"expressing":[51],"CD19+,":[52],"CD5+":[53],"CD23+":[55],"typically":[56,122],"infiltrating":[57],"lymph":[59],"system,":[60],"spleen":[61],"bone":[63],"marrow":[64],"susceptible":[66],"persons.":[67],"Treatment":[68],"via":[72],"monotherapy":[73],"alkylating":[75],"agents":[76],"such":[77,109,119],"as":[78,110,114,128,273],"chlorambucil":[79,91,174,202,261],"elderly":[81],"patients.":[82],"As":[83],"relatively":[85],"cheap":[86],"chemotherapeutic":[87],"low":[89,98],"toxicity":[90,151],"has":[92],"disadvantage":[94],"having":[96],"response":[99],"risk":[101],"side":[103],"effects":[104],"including":[105],"myelodysplasia.":[106],"Monoclonal":[107],"antibodies":[108],"Alemtuzumab":[111],"have":[112,271],"emerged":[113],"an":[115,129,136],"alternative/combination":[116],"therapy":[117,120,141],"however;":[118],"more":[123],"expensive":[124],"less":[126,235],"convenient":[127],"IV":[130],"injection.":[131],"This":[132],"study":[133],"reports":[134],"on":[135],"investigation":[137],"into":[138],"novel":[139],"drug":[140],"options":[142],"treatment":[144],"provides":[148],"comparative":[150],"profile":[152],"against":[153,203,239],"non-tumour":[154,224],"cells":[155,205],"to":[156],"determine":[157],"selectivity.":[158],"Five":[159],"synthetic":[160,250],"1,":[161,258,267],"2,":[162,268],"4,":[163,269],"5-tetraoxanes,":[164],"semi-synthetic":[166],"artemisinin":[167],"derivative":[168],"dihydroartemisinin":[169],"(DHA)":[170],"clinically":[172],"used":[173],"were":[175],"evaluated":[176],"their":[178],"antiproliferative":[179,210,236],"activity":[180,237],"two":[182],"leukemic":[183],"cell":[184,230,242],"lines":[185],"at":[186],"physiologically":[187],"relevant":[188],"oxygen":[189],"tension":[190],"(5%":[191],"v/v).":[192],"All":[193],"five":[194],"tetraoxanes":[195,214],"DHA":[197,216,263],"performed":[198],"significantly":[199],"better":[200],"that":[201,266],"HL-60":[204,241],"single":[207],"digit":[208],"micromolar":[209],"IC50":[211],"values.":[212],"Three":[213],"also":[217],"displayed":[218],"higher":[219],"selectivity":[220,254],"tumour":[222],"over":[223],"cells.":[225],"Against":[226],"hard-to-treat":[228],"MEC-1":[229],"line,":[231],"all":[232],"compounds":[233],"showed":[234],"than":[238,257],"line.":[243],"Only":[244],"one":[245],"these":[247],"compounds,":[248],"tetraoxane,":[251],"had":[252],"index":[255],"greater":[256],"outperforming":[259],"both":[260],"demonstrating":[265],"5-tetraoxanes":[270],"potential":[272],"new":[275],"class":[276],"anti-leukemia":[278],"therapeutics.":[279]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-06-19T00:00:00"}